Henry Meds Review 2026: Strong Doctors, But Better Deals Exist

Henry Meds is one of the largest telehealth companies operating in GLP-1 weight loss — they've built a national network of licensed physicians, a streamlined intake process, and a reputation for fast prescription turnaround. But size and reputation aren't the same as value. This Henry Meds review applies our independent 25/25/20/15/15 scoring methodology to answer the real question: is $197/month for compounded semaglutide the best way to spend your weight-loss budget in 2026? Our Henry Meds review finds a company with genuine clinical strengths — and a price premium that most patients don't need to pay.

Short answer: Henry Meds earns a strong 8.5/10 on clinical oversight — one of the highest physician-quality scores in our ranking. But at ~$197/mo they're priced higher than our vetted affiliate partners who match or beat them on every other criterion. For patients who want a large, well-staffed telehealth operation but aren't locked to the Henry Meds name, there are better deals at $133–$149/mo.

Independent Editor · Scores based on our editorial policy · Verified 2026-07-21 · Independently researched

What Is Henry Meds? (Henry Meds Review Background)

Henry Meds launched in 2020 as a testosterone replacement therapy (TRT) telehealth platform. Over the next three years they expanded their model — physician network, intake system, pharmacy partnerships — into hormone replacement therapy, hair loss, sexual health, and eventually GLP-1 weight loss. By 2025, GLP-1 programs had become a significant part of their patient base.

Today, Henry Meds operates one of the most physician-dense networks among GLP-1 telehealth companies. Their model:

1. Complete a digital health intake on their website or app
2. A U.S.-licensed physician reviews your medical history and lab work
3. If eligible, a prescription is sent to a licensed 503A compounding pharmacy
4. Compounded semaglutide or tirzepatide ships directly to your door
5. Ongoing physician follow-ups for titration adjustments and dose management

What Henry Meds does well at the process level is speed. They've invested in intake-to-prescription infrastructure such that most patients report same-day or next-day physician review — faster than many smaller telehealth startups where a board-certified obesity specialist is a bottleneck.

What they haven't invested in: the lowest price point, brand-name GLP-1 access, or a particularly polished consumer app experience.

How Much Does Henry Meds Cost in 2026?

The most common question in any Henry Meds review: what does it actually cost? Compounded semaglutide starts at approximately $197/month through Henry Meds, based on reporting from Healthline, Forbes Health, and CNBC from 2025–2026. Compounded tirzepatide is available at a higher price point.

Before you complete intake, a few pricing realities to understand:

The $197 reflects the starting dose. GLP-1 programs typically begin at 0.25mg/week semaglutide — the introductory microdose. The $197/mo figure reflects this tier. As titration increases toward the 1mg/week or 2.4mg/week maintenance range, monthly cost rises. This is true across all compounded GLP-1 providers, but it's important context: your actual annualized cost will be higher than the advertised starting price.

Pricing is transparent upfront. To Henry Meds's credit, they publish starting price information before you're required to complete intake. This puts them ahead of providers that withhold pricing until after you submit your health history — a transparency standard we consider a minimum for a responsible GLP-1 provider.

No brand-name GLP-1. Henry Meds prescribes compounded semaglutide and tirzepatide only. If you have employer health insurance that covers Wegovy or Zepbound, Henry Meds cannot fulfill a brand-name prescription. The only provider in our full ranking that offers both compounded and brand-name access (Wegovy, Ozempic, Mounjaro, Zepbound) is Wellorithm.

How Henry Meds pricing compares to our affiliate partners:

⚠️ Disclosure: We have active affiliate partnerships with Wellorithm, Gala Health, Yucca Health, and Oak. We receive no commission from Henry Meds; this is an independent editorial review. Our scores are calculated from our editorial policy — commission has never influenced a score on this site.

Henry Meds Review: Clinical Oversight (Where They Actually Excel)

Clinical oversight accounts for 25% of our total score, and this is where our Henry Meds review finds the strongest case for the service: they receive 8.5/10 on clinical quality — one of the highest scores in our 19-provider ranking.

What drives that score:

Large licensed-physician network. Henry Meds employs or contracts with a substantial network of U.S.-licensed physicians across states. Each patient is matched with a physician licensed in their home state — not an out-of-state teleconsult that creates prescribing gray areas. This structural decision reflects genuine clinical rigor.

Fast intake-to-prescription. Most patients report same-day or next-day physician review and prescription, based on reviews across Trustpilot and Reddit (r/Semaglutide). For a patient who has been waiting months for a primary care referral or an endocrinologist appointment, this speed is clinically meaningful.

Ongoing follow-up. Henry Meds includes physician follow-ups for dose titration and side effect management. This is standard across most reputable telehealth GLP-1 programs, but it's worth confirming before choosing any provider — some low-cost platforms provide a prescription and little else.

What "8.5/10 but not 9.5/10" means here: the score is docked relative to the top tier because Henry Meds's physician network, while large, is built primarily around high-volume intake processing rather than specialized obesity medicine. Providers like Gala Health, which uses a dedicated microdosing protocol with ongoing clinical customization, or Synergy RX, whose individualized high-touch support earns it our "Best Support" designation, operate at a more specialist clinical intensity. Henry Meds's clinical infrastructure is strong; it just skews toward throughput over depth.

Henry Meds Review: Treatment Options (Compounded Sema and Tirz Only)

Henry Meds's treatment menu earns a 7.5/10 — solid but not the widest selection in the field.

What they offer:

• Compounded semaglutide — the core product, injection-based
• Compounded tirzepatide — available as a step-up or alternative for patients who need the dual GLP-1/GIP mechanism

What they don't offer:

• Brand-name Wegovy, Ozempic, Mounjaro, or Zepbound
• Oral/sublingual semaglutide (not confirmed as available)
• Additional vertical services (hair, sexual health, NAD+) that multi-service telehealth platforms include

For most GLP-1 candidates — patients without insurance coverage for brand-name medication, seeking compounded options at cash prices — this menu is sufficient. If you specifically want access to brand-name Wegovy for the FDA-approved formulation, or oral semaglutide as a needle-free alternative, Henry Meds is not your best option.

For a full comparison of compounded vs brand-name options, see our guide: Compounded vs Brand Semaglutide: Cost, Safety & How to Choose. The FDA also provides guidance for patients considering compounded GLP-1 medications: FDA clarifies policies for compounders as GLP-1 supply stabilizes.

Henry Meds Review: User Experience (Functional, Not Consumer-First)

Henry Meds's experience score is 7.5/10 in this Henry Meds review — respectable, but a step below the consumer-app experience leaders (Hims at 9.0/10, Ro at 8.5/10) in our ranking.

What works:

• Fast intake process — the majority of reviews note that the time from "I signed up" to "I received my prescription" is short
• Upfront pricing, clear program structure
• Responsive support channels for most documented patient interactions

What's less polished:

• The patient portal and mobile experience are functional but not designed with the same consumer-product investment as Hims or Ro, both of which came from direct-to-consumer software backgrounds before they ever wrote a prescription
• Independent review volume on platforms like Trustpilot is moderate compared to companies like Yucca Health (4.6/5 from 1,000+ reviews) or Noom Med (which benefits from the parent Noom platform's scale)
• The full pricing tier structure — what you'll pay at maintenance doses — requires completing intake to access, rather than being fully displayed upfront. This is a transparency limitation.

For patients who prioritize speed and clinical quality above a sleek mobile interface, Henry Meds's experience level is fine. For patients who want the "best app in class" with behavior-change coaching, real-time tracking, and a polished digital product, there are better fits.

Henry Meds Review: Transparency and Trust (Above Average, With Caveats)

Henry Meds earns 7.5/10 on transparency in our Henry Meds review — above the median in our ranking, but with limitations that prevent a higher score.

Positive signals:

• Starting price is disclosed publicly before completing intake
• Licensing disclosures: physicians are U.S.-licensed in-state; pharmacy partners are disclosed as 503A compounders
• Compounded-not-FDA-approved disclaimer is present
• Henry Meds is an established company with a multi-year operating history and growing patient base

Limitations:

• Full pricing tiers (starting dose → maintenance dose cost progression) are not fully displayed before intake. This is the most significant transparency gap — compounded GLP-1 patients often don't discover their maintenance-dose monthly cost until after they've started the program.
• The states-served list is not prominently published. Most U.S. patients will be covered, but patients in specific states should confirm coverage before beginning intake.
• Independent third-party review volume is moderate relative to the company's scale. Henry Meds processes a large number of patients, but the independent review corpus is thinner than expected for a provider their size.

Henry Meds Review vs Our Top-Rated Partners

The core finding of this Henry Meds review is the value gap. At $197/mo, Henry Meds charges a premium that isn't justified by a uniquely better clinical outcome, a wider treatment menu, or superior user experience compared to our vetted affiliate partners.

Here's a fuller comparison across the criteria that matter:

Henry Meds's clinical score (8.5) is the highest of this group on that individual dimension. But Wellorithm and Gala Health achieve 8.3/10 overall while costing $50/mo less — because they make up the clinical gap with stronger treatment menus (Wellorithm's brand-name access is unique) and better overall value. Even Yucca Health, which matches Henry Meds at 7.8 overall, starts at $50/mo less.

The bottom line: if you're drawn to Henry Meds specifically because of their physician network reputation, that reputation is real. But equivalent or better clinical outcomes are achievable at meaningfully lower cost through our partner providers.

Who Should Choose Henry Meds?

Despite our critique of the price point, Henry Meds is the right choice for some patients:

Good fit if:

• You've specifically researched Henry Meds and trust their brand from prior hormone-therapy experience (many of their patients come from their TRT/HRT programs)
• You prioritize the largest physician network and fast intake-to-prescription above cost
• You're in a state where our affiliate partners have coverage limitations (verify before choosing any provider)

Better alternatives if:

• You want the best overall score at the lowest price → Gala Health ($149/mo, 8.3/10) or Oak ($133/mo, 7.7/10)
• You want brand-name Wegovy/Zepbound access → Wellorithm ($147/mo, 8.3/10) — the only provider in our ranking with brand-name GLP-1
• You want the best value on a Yucca-tier clinical program → Yucca Health ($146/mo, 7.8/10 — same score as Henry Meds, $51/mo less)
• You want multiple services under one login (GLP-1 + hair + sexual health) → Care Bare Rx ($199/mo, multi-vertical)

See our full ranking for a side-by-side view: Best Online Semaglutide Providers 2026.

Frequently Asked Questions About Henry Meds Review

Yes, Henry Meds is a legitimate telehealth provider. They work with U.S.-licensed physicians who prescribe from licensed 503A compounding pharmacies. Compounded semaglutide is not FDA-approved, but the prescribing and dispensing process is legal under current 503A pharmacy rules. Henry Meds has operated since 2020 across multiple health verticals.

Compounded semaglutide through Henry Meds starts at approximately $197/mo based on public health journalism reporting from 2025–2026. Tirzepatide is available at a higher price. Costs increase at higher maintenance doses — the starting price reflects the introductory low dose. For comparison, our vetted affiliate partners start at $133–$149/mo for comparable compounded programs.

Henry Meds operates as a cash-pay telehealth platform for compounded GLP-1. They do not bill insurance for compounded semaglutide or tirzepatide, nor do they prescribe brand-name Wegovy or Zepbound (which are the medications most likely to be covered by commercial insurance). If insurance coverage for GLP-1 is important to you, see our guide: Does Insurance Cover GLP-1 for Weight Loss?.

At $197/mo, Henry Meds is priced $50+/mo above Wellorithm ($147) and Gala Health ($149), while scoring lower overall (7.8 vs 8.3/10). Wellorithm's primary advantage over Henry Meds is brand-name GLP-1 access — Wellorithm is the only provider in our ranking that dispenses Wegovy, Ozempic, Mounjaro, and Zepbound in addition to compounded formulations. Gala Health matches Henry Meds clinically while offering a proprietary microdosing protocol and a more polished patient experience. Both are affiliate partners; Henry Meds is editorial-only. See the comparison: Wellorithm vs Henry Meds.

Our Top Picks for GLP-1 Weight Loss

Our Henry Meds review finds a provider that earns a solid 7.8/10 — above the midpoint of our 19-provider ranking — on the strength of their physician infrastructure. But this Henry Meds review also finds that their pricing premium is not justified by a meaningfully better outcome for most patients.

If you're ready to start:

⚠️ Medical disclaimer: Compounded semaglutide and tirzepatide are not FDA-approved drugs. They are prepared by licensed 503A compounding pharmacies under a valid prescription. Always consult a licensed healthcare provider to determine whether GLP-1 medication is appropriate for your medical history. This review is for informational purposes only and does not constitute medical advice.

⚠️ Affiliate disclosure: We earn a commission when you use our links to Wellorithm, Gala Health, Yucca Health, and Oak. We do not earn a commission from Henry Meds — this is an editorial review. Our scoring methodology is independent of commercial relationships. See our affiliate disclosure and editorial policy.

Last updated: August 2026 · Prices sourced from public health journalism (Healthline, Forbes Health, CNBC 2025–2026); direct re-verification pending next Weekly Maintenance.

Related Reading

• Best Online Semaglutide Providers 2026 — Full Ranking
• Compounded vs Brand Semaglutide: Cost, Safety & How to Choose
• Is Compounded Semaglutide Still Legal in 2026?
• Semaglutide vs Tirzepatide: Which Is Right for You?
• GLP-1 Weight Loss Cost in 2026: All-In Prices Compared
• Wellorithm Review 2026
• Gala Health Review 2026
• Yucca Health Review 2026
• Oak Review 2026